Rybelsus 3 mg

Rybelsus 3 mg is an oral medication designed to support blood sugar regulation in adults with type 2 diabetes. Its active ingredient, semaglutide, helps enhance insulin secretion and lower glucagon levels, contributing to improved glycemic control. Taken once daily, this treatment offers a convenient alternative to injectable therapies, aiding in effective diabetes management when combined with diet and exercise.